Clinical trial

Alendronate Osteoporosis Study

NCT00277251

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-03-01

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2003-03-01Date precision: month

Registry last updated2017-04-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glucocorticoid-Associated Osteopenia and Osteoporosisunresolved

Interventions

AlendronateDRUG

Sponsors & collaborators

Boston Children's Hospitallead sponsor

Glaser Pediatric Research Networkcollaborator

Elizabeth Glaser Pediatric AIDS Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00277251 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.